310 related articles for article (PubMed ID: 18202103)
1. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.
O'Keeffe FE; Scott SA; Tyers P; O'Keeffe GW; Dalley JW; Zufferey R; Caldwell MA
Brain; 2008 Mar; 131(Pt 3):630-41. PubMed ID: 18202103
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
Grothe C; Timmer M; Scholz T; Winkler C; Nikkhah G; Claus P; Itoh N; Arenas E
Neurobiol Dis; 2004 Nov; 17(2):163-70. PubMed ID: 15474354
[TBL] [Abstract][Full Text] [Related]
3. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
[TBL] [Abstract][Full Text] [Related]
4. Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.
Timmer M; Müller-Ostermeyer F; Kloth V; Winkler C; Grothe C; Nikkhah G
Exp Neurol; 2004 May; 187(1):118-36. PubMed ID: 15081594
[TBL] [Abstract][Full Text] [Related]
5. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.
Jönsson ME; Ono Y; Björklund A; Thompson LH
Exp Neurol; 2009 Sep; 219(1):341-54. PubMed ID: 19555687
[TBL] [Abstract][Full Text] [Related]
6. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.
Wagner J; Akerud P; Castro DS; Holm PC; Canals JM; Snyder EY; Perlmann T; Arenas E
Nat Biotechnol; 1999 Jul; 17(7):653-9. PubMed ID: 10404157
[TBL] [Abstract][Full Text] [Related]
7. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
8. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
9. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats.
Ben-Hur T; Idelson M; Khaner H; Pera M; Reinhartz E; Itzik A; Reubinoff BE
Stem Cells; 2004; 22(7):1246-55. PubMed ID: 15579643
[TBL] [Abstract][Full Text] [Related]
11. The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias.
Kuan WL; Lin R; Tyers P; Barker RA
Neurobiol Dis; 2007 Mar; 25(3):594-608. PubMed ID: 17188499
[TBL] [Abstract][Full Text] [Related]
12. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
13. Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain.
Thompson LH; Kirik D; Björklund A
Exp Neurol; 2008 Sep; 213(1):220-8. PubMed ID: 18602916
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule.
Ourednik V; Ourednik J; Xu Y; Zhang Y; Lynch WP; Snyder EY; Schachner M
Stem Cells; 2009 Nov; 27(11):2846-56. PubMed ID: 19785036
[TBL] [Abstract][Full Text] [Related]
15. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
16. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic properties and function after grafting of attached neural precursor cultures.
Timmer M; Grosskreutz J; Schlesinger F; Krampfl K; Wesemann M; Just L; Bufler J; Grothe C
Neurobiol Dis; 2006 Mar; 21(3):587-606. PubMed ID: 16256357
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene.
Li QJ; Tang YM; Liu J; Zhou DY; Li XP; Xiao SH; Jian DX; Xing YG
Synapse; 2007 Dec; 61(12):971-7. PubMed ID: 17879263
[TBL] [Abstract][Full Text] [Related]
19. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Vazey EM; Chen K; Hughes SM; Connor B
Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
